Source: EMBO Molecular Medicine. Unidade: IQ
Subjects: NEURÔNIOS, ORGANELAS CELULARES, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRUJILLO, Cleber A et al. Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids. EMBO Molecular Medicine, v. 13, p. 1-18 art. e12523, 2021Tradução . . Disponível em: https://doi.org/10.15252/emmm.202012523. Acesso em: 17 maio 2024.APA
Trujillo, C. A., Adams, J. W., Negraes, P. D., Carromeu, C., Tejwani, L., Acab, A., et al. (2021). Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids. EMBO Molecular Medicine, 13, 1-18 art. e12523. doi:10.15252/emmm.202012523NLM
Trujillo CA, Adams JW, Negraes PD, Carromeu C, Tejwani L, Acab A, Tsuda B, Thomas CA, Sodhi N, Fichter KM, Romero S, Zanella F, Sejnowski TJ, Ulrich H, Muotri AR. Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids [Internet]. EMBO Molecular Medicine. 2021 ; 13 1-18 art. e12523.[citado 2024 maio 17 ] Available from: https://doi.org/10.15252/emmm.202012523Vancouver
Trujillo CA, Adams JW, Negraes PD, Carromeu C, Tejwani L, Acab A, Tsuda B, Thomas CA, Sodhi N, Fichter KM, Romero S, Zanella F, Sejnowski TJ, Ulrich H, Muotri AR. Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids [Internet]. EMBO Molecular Medicine. 2021 ; 13 1-18 art. e12523.[citado 2024 maio 17 ] Available from: https://doi.org/10.15252/emmm.202012523